chr19-52190287-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 1P and 9B. PP2BP4_StrongBS1_SupportingBS2
The ENST00000454220.7(PPP2R1A):c.191C>T(p.Pro64Leu) variant causes a missense change. The variant allele was found at a frequency of 0.031 in 1,227,742 control chromosomes in the GnomAD database, including 740 homozygotes. In-silico tool predicts a benign outcome for this variant. 8/12 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as not provided (no stars).
Frequency
Genomes: 𝑓 0.023 ( 60 hom., cov: 33)
Exomes 𝑓: 0.032 ( 680 hom. )
Consequence
PPP2R1A
ENST00000454220.7 missense
ENST00000454220.7 missense
Scores
1
4
9
Clinical Significance
Conservation
PhyloP100: 3.72
Genes affected
PPP2R1A (HGNC:9302): (protein phosphatase 2 scaffold subunit Aalpha) This gene encodes a constant regulatory subunit of protein phosphatase 2. Protein phosphatase 2 is one of the four major Ser/Thr phosphatases, and it is implicated in the negative control of cell growth and division. It consists of a common heteromeric core enzyme, which is composed of a catalytic subunit and a constant regulatory subunit, that associates with a variety of regulatory subunits. The constant regulatory subunit A serves as a scaffolding molecule to coordinate the assembly of the catalytic subunit and a variable regulatory B subunit. This gene encodes an alpha isoform of the constant regulatory subunit A. Alternatively spliced transcript variants have been described. [provided by RefSeq, Apr 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), PPP2R1A. . Gene score misZ 4.4565 (greater than the threshold 3.09). Trascript score misZ 4.3877 (greater than threshold 3.09). GenCC has associacion of gene with intellectual disability, autosomal dominant 40, Houge-Janssens syndrome 2, complex neurodevelopmental disorder.
BP4
Computational evidence support a benign effect (MetaRNN=0.005302608).
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0232 (3531/152348) while in subpopulation NFE AF= 0.0375 (2552/68026). AF 95% confidence interval is 0.0363. There are 60 homozygotes in gnomad4. There are 1630 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 3531 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PPP2R1A | NM_014225.6 | c.78+113C>T | intron_variant | ENST00000322088.11 | NP_055040.2 | |||
PPP2R1A | NR_033500.2 | n.123+113C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PPP2R1A | ENST00000322088.11 | c.78+113C>T | intron_variant | 1 | NM_014225.6 | ENSP00000324804 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0232 AC: 3530AN: 152230Hom.: 60 Cov.: 33
GnomAD3 genomes
AF:
AC:
3530
AN:
152230
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0220 AC: 2361AN: 107370Hom.: 51 AF XY: 0.0225 AC XY: 1278AN XY: 56892
GnomAD3 exomes
AF:
AC:
2361
AN:
107370
Hom.:
AF XY:
AC XY:
1278
AN XY:
56892
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0321 AC: 34476AN: 1075394Hom.: 680 Cov.: 14 AF XY: 0.0322 AC XY: 17279AN XY: 537418
GnomAD4 exome
AF:
AC:
34476
AN:
1075394
Hom.:
Cov.:
14
AF XY:
AC XY:
17279
AN XY:
537418
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0232 AC: 3531AN: 152348Hom.: 60 Cov.: 33 AF XY: 0.0219 AC XY: 1630AN XY: 74504
GnomAD4 genome
AF:
AC:
3531
AN:
152348
Hom.:
Cov.:
33
AF XY:
AC XY:
1630
AN XY:
74504
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
141
ALSPAC
AF:
AC:
148
ExAC
AF:
AC:
363
Asia WGS
AF:
AC:
30
AN:
3478
ClinVar
Significance: not provided
Submissions summary: Other:1
Revision: no classification provided
LINK: link
Submissions by phenotype
not specified Other:1
not provided, no classification provided | reference population | ITMI | Sep 19, 2013 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Benign
D
LIST_S2
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationTaster
Benign
D;D;D
PROVEAN
Benign
N
REVEL
Benign
Sift
Uncertain
D
Sift4G
Pathogenic
D
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at